Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3108522 | Critical Care Clinics | 2009 | 17 Pages |
Abstract
Allogeneic blood transfusions have been associated with several risks and complications and with worse outcomes in a substantial number of patient populations and clinical scenarios. Allogeneic blood is costly and difficult to procure, transport, and store. Global and local shortages are imminent. Alternatives to transfusion provide many advantages, and their use is likely to improve outcomes as safer and more effective agents are developed.
Related Topics
Health Sciences
Medicine and Dentistry
Critical Care and Intensive Care Medicine
Authors
Aryeh Shander, Lawrence Tim Goodnough,